Epigastric abdominal pain: Difference between revisions

(7 intermediate revisions by 4 users not shown)
Line 10: Line 10:
*CBC
*CBC
*Chem
*Chem
*LFTs
*[[LFTs]]
*Lipase
*Lipase
*Coags
*Coags
*UA
*[[Urinalysis]]
*Urine pregnancy (females)
*Urine pregnancy (females)
*?ECG (if >50 or at risk for cardiac disease)
*?[[ECG]] (if >50 or at risk for cardiac disease)
*?[[RUQ US]]
*?[[RUQ US]]
*?CXR
*?[[CXR]]
**Consider if at risk for perforated ulcer
**Consider if at risk for perforated ulcer


==Management==
==Management==
*Treat underlying disease process
*Treat underlying disease process
*Consider GI cocktail
*Consider PO antacid (e.g. [[Bismuth subsalicylate|Maalox]] Plus)
**The addition of viscous [[lidocaine]]  2% and/or Donnatol (i.e. "GI Cocktail") is no more effective than plain liquid antacid<ref>Berman DA, Porter RS, Graber M. "The GI Cocktail is no more effective than plain liquid antacid: a randomized, double blind clinical trial." J Emerg Med. 2003 Oct;25(3):239-44.</ref>


==Disposition==
==Disposition==
Line 33: Line 34:
==External Links==
==External Links==


==Sources==
==References==
<references/>
<references/>


[[Category:GI]]
[[Category:GI]]
[[Category:Symptoms]]

Revision as of 15:22, 14 September 2019

Background

  • This page outlines the general approach to adult epigastric pain

Clinical Features

Differential Diagnosis

Epigastric Pain

Workup

  • CBC
  • Chem
  • LFTs
  • Lipase
  • Coags
  • Urinalysis
  • Urine pregnancy (females)
  • ?ECG (if >50 or at risk for cardiac disease)
  • ?RUQ US
  • ?CXR
    • Consider if at risk for perforated ulcer

Management

  • Treat underlying disease process
  • Consider PO antacid (e.g. Maalox Plus)
    • The addition of viscous lidocaine 2% and/or Donnatol (i.e. "GI Cocktail") is no more effective than plain liquid antacid[1]

Disposition

  • Disposition per underlying disease process

See Also

External Links

References

  1. Berman DA, Porter RS, Graber M. "The GI Cocktail is no more effective than plain liquid antacid: a randomized, double blind clinical trial." J Emerg Med. 2003 Oct;25(3):239-44.